China Artemisinin Derivatives Market Research Report 2017

December 2017 | 101 pages | ID: CA63164859AEN
QYResearch

Abstracts

The global Artemisinin Derivatives market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Artemisinin Derivatives development status and future trend in China, focuses on top players in China, also splits Artemisinin Derivatives by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Sanofi
• KPC Pharmaceuticals
• Guangxi Xiancaotang Pharmaceutical
• Guilin Pharmaceutical
• Kerui Nanhai Pharmaceutical
• Shanghai Natural Bio-engineering Co
• Novanat Bioresource
• Botanical Extracts EPZ Ltd

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into

• Dihydroartemisinin
• Artemisunate
• Others

On the basis of the end users/application, this report covers

• Malaria Treatment
• Scientific Research
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Artemisinin Derivatives Market Research Report 2017

1 ARTEMISININ DERIVATIVES OVERVIEW

1.1 Product Overview and Scope of Artemisinin Derivatives
1.2 Classification of Artemisinin Derivatives by Product Category
  1.2.1 China Artemisinin Derivatives Sales (K MT) Comparison by Type (2012-2022)
  1.2.2 China Artemisinin Derivatives Sales (K MT) Market Share by Type in 2016
  1.2.3 Dihydroartemisinin
  1.2.4 Artemisunate
  1.2.5 Others
1.3 China Artemisinin Derivatives Market by Application/End Users
  1.3.1 China Artemisinin Derivatives Sales (K MT) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Malaria Treatment
  1.3.3 Scientific Research
  1.3.4 Others
1.4 China Artemisinin Derivatives Market by Region
  1.4.1 China Artemisinin Derivatives Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China Artemisinin Derivatives Status and Prospect (2012-2022)
  1.4.3 East China Artemisinin Derivatives Status and Prospect (2012-2022)
  1.4.4 Southwest China Artemisinin Derivatives Status and Prospect (2012-2022)
  1.4.5 Northeast China Artemisinin Derivatives Status and Prospect (2012-2022)
  1.4.6 North China Artemisinin Derivatives Status and Prospect (2012-2022)
  1.4.7 Central China Artemisinin Derivatives Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Artemisinin Derivatives (2012-2022)
  1.5.1 China Artemisinin Derivatives Sales (K MT) and Growth Rate (%)(2012-2022)
  1.5.2 China Artemisinin Derivatives Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA ARTEMISININ DERIVATIVES MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Artemisinin Derivatives Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Artemisinin Derivatives Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Artemisinin Derivatives Average Price (USD/MT) by Players/Manufacturers (2012-2017)
2.4 China Artemisinin Derivatives Market Competitive Situation and Trends
  2.4.1 China Artemisinin Derivatives Market Concentration Rate
  2.4.2 China Artemisinin Derivatives Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Artemisinin Derivatives Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA ARTEMISININ DERIVATIVES SALES AND REVENUE BY REGION (2012-2017)

3.1 China Artemisinin Derivatives Sales (K MT) and Market Share by Region (2012-2017)
3.2 China Artemisinin Derivatives Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Artemisinin Derivatives Price (USD/MT) by Regions (2012-2017)

4 CHINA '&B1&' SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)'

4.1 China Artemisinin Derivatives Sales (K MT) and Market Share by Type/ Product Category (2012-2017)
4.2 China Artemisinin Derivatives Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Artemisinin Derivatives Price (USD/MT) by Type (2012-2017)
4.4 China Artemisinin Derivatives Sales Growth Rate (%) by Type (2012-2017)

5 CHINA '&B1&' SALES BY APPLICATION (2012-2017)'

5.1 China Artemisinin Derivatives Sales (K MT) and Market Share by Application (2012-2017)
5.2 China Artemisinin Derivatives Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA ARTEMISININ DERIVATIVES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sanofi
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Artemisinin Derivatives Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi Artemisinin Derivatives Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 KPC Pharmaceuticals
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Artemisinin Derivatives Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 KPC Pharmaceuticals Artemisinin Derivatives Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Guangxi Xiancaotang Pharmaceutical
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Artemisinin Derivatives Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Guilin Pharmaceutical
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Artemisinin Derivatives Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Guilin Pharmaceutical Artemisinin Derivatives Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Kerui Nanhai Pharmaceutical
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Artemisinin Derivatives Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Shanghai Natural Bio-engineering Co
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Artemisinin Derivatives Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Novanat Bioresource
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Artemisinin Derivatives Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novanat Bioresource Artemisinin Derivatives Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Botanical Extracts EPZ Ltd
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Artemisinin Derivatives Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.8.4 Main Business/Business Overview

7 ARTEMISININ DERIVATIVES MANUFACTURING COST ANALYSIS

7.1 Artemisinin Derivatives Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Artemisinin Derivatives

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Artemisinin Derivatives Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Artemisinin Derivatives Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA ARTEMISININ DERIVATIVES MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China Artemisinin Derivatives Sales (K MT), Revenue (Million USD) Forecast (2017-2022)
11.2 China Artemisinin Derivatives Sales (K MT) Forecast by Type (2017-2022)
11.3 China Artemisinin Derivatives Sales (K MT) Forecast by Application (2017-2022)
11.4 China Artemisinin Derivatives Sales (K MT) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Artemisinin Derivatives Sales (K MT) and Revenue (Million USD) Market Split by Product Type
Table Artemisinin Derivatives Sales (K MT) by Application (2016-2022)
Figure Product Picture of Artemisinin Derivatives
Table China Artemisinin Derivatives Sales (K MT) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Artemisinin Derivatives Sales Volume Market Share by Types in 2016
Figure Dihydroartemisinin Product Picture
Figure Artemisunate Product Picture
Figure Others Product Picture
Figure China Artemisinin Derivatives Sales (K MT) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Artemisinin Derivatives by Application in 2016
Figure Malaria Treatment Examples
Table Key Downstream Customer in Malaria Treatment
Figure Scientific Research Examples
Table Key Downstream Customer in Scientific Research
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Artemisinin Derivatives Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Artemisinin Derivatives Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Artemisinin Derivatives Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Artemisinin Derivatives Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Artemisinin Derivatives Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Artemisinin Derivatives Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Artemisinin Derivatives Sales (K MT) and Growth Rate (%)(2012-2022)
Figure China Artemisinin Derivatives Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Artemisinin Derivatives Sales of Key Players/Manufacturers (2012-2017)
Table China Artemisinin Derivatives Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Artemisinin Derivatives Sales Share (%) by Players/Manufacturers
Figure 2017 China Artemisinin Derivatives Sales Share (%) by Players/Manufacturers
Table China Artemisinin Derivatives Revenue by Players/Manufacturers (2012-2017)
Table China Artemisinin Derivatives Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Artemisinin Derivatives Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Artemisinin Derivatives Revenue Market Share (%) by Players/Manufacturers
Table China Market Artemisinin Derivatives Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Artemisinin Derivatives Average Price of Key Players/Manufacturers in 2016
Figure China Artemisinin Derivatives Market Share of Top 3 Players/Manufacturers
Figure China Artemisinin Derivatives Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Artemisinin Derivatives Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Artemisinin Derivatives Product Category
Table China Artemisinin Derivatives Sales (K MT) by Regions (2012-2017)
Table China Artemisinin Derivatives Sales Share (%) by Regions (2012-2017)
Figure China Artemisinin Derivatives Sales Share (%) by Regions (2012-2017)
Figure China Artemisinin Derivatives Sales Market Share (%) by Regions in 2016
Table China Artemisinin Derivatives Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Artemisinin Derivatives Revenue Market Share (%) by Regions (2012-2017)
Figure China Artemisinin Derivatives Revenue Market Share (%) by Regions (2012-2017)
Figure China Artemisinin Derivatives Revenue Market Share (%) by Regions in 2016
Table China Artemisinin Derivatives Price (USD/MT) by Regions (2012-2017)
Table China Artemisinin Derivatives Sales (K MT) by Type (2012-2017)
Table China Artemisinin Derivatives Sales Share (%) by Type (2012-2017)
Figure China Artemisinin Derivatives Sales Share (%) by Type (2012-2017)
Figure China Artemisinin Derivatives Sales Market Share (%) by Type in 2016
Table China Artemisinin Derivatives Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Artemisinin Derivatives Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Artemisinin Derivatives by Type (2012-2017)
Figure Revenue Market Share of Artemisinin Derivatives by Type in 2016
Table China Artemisinin Derivatives Price (USD/MT) by Types (2012-2017)
Figure China Artemisinin Derivatives Sales Growth Rate (%) by Type (2012-2017)
Table China Artemisinin Derivatives Sales (K MT) by Applications (2012-2017)
Table China Artemisinin Derivatives Sales Market Share (%) by Applications (2012-2017)
Figure China Artemisinin Derivatives Sales Market Share (%) by Application (2012-2017)
Figure China Artemisinin Derivatives Sales Market Share (%) by Application in 2016
Table China Artemisinin Derivatives Sales Growth Rate (%) by Application (2012-2017)
Figure China Artemisinin Derivatives Sales Growth Rate (%) by Application (2012-2017)
Table Sanofi Artemisinin Derivatives Basic Information List
Table Sanofi Artemisinin Derivatives Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Sanofi Artemisinin Derivatives Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Sanofi Artemisinin Derivatives Sales Market Share (%) in China (2012-2017)
Figure Sanofi Artemisinin Derivatives Revenue Market Share (%) in China (2012-2017)
Table KPC Pharmaceuticals Artemisinin Derivatives Basic Information List
Table KPC Pharmaceuticals Artemisinin Derivatives Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure KPC Pharmaceuticals Artemisinin Derivatives Sales (K MT) and Growth Rate (%)(2012-2017)
Figure KPC Pharmaceuticals Artemisinin Derivatives Sales Market Share (%) in China (2012-2017)
Figure KPC Pharmaceuticals Artemisinin Derivatives Revenue Market Share (%) in China (2012-2017)
Table Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Basic Information List
Table Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales Market Share (%) in China (2012-2017)
Figure Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Revenue Market Share (%) in China (2012-2017)
Table Guilin Pharmaceutical Artemisinin Derivatives Basic Information List
Table Guilin Pharmaceutical Artemisinin Derivatives Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Guilin Pharmaceutical Artemisinin Derivatives Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Guilin Pharmaceutical Artemisinin Derivatives Sales Market Share (%) in China (2012-2017)
Figure Guilin Pharmaceutical Artemisinin Derivatives Revenue Market Share (%) in China (2012-2017)
Table Kerui Nanhai Pharmaceutical Artemisinin Derivatives Basic Information List
Table Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales Market Share (%) in China (2012-2017)
Figure Kerui Nanhai Pharmaceutical Artemisinin Derivatives Revenue Market Share (%) in China (2012-2017)
Table Shanghai Natural Bio-engineering Co Artemisinin Derivatives Basic Information List
Table Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales Market Share (%) in China (2012-2017)
Figure Shanghai Natural Bio-engineering Co Artemisinin Derivatives Revenue Market Share (%) in China (2012-2017)
Table Novanat Bioresource Artemisinin Derivatives Basic Information List
Table Novanat Bioresource Artemisinin Derivatives Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Novanat Bioresource Artemisinin Derivatives Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Novanat Bioresource Artemisinin Derivatives Sales Market Share (%) in China (2012-2017)
Figure Novanat Bioresource Artemisinin Derivatives Revenue Market Share (%) in China (2012-2017)
Table Botanical Extracts EPZ Ltd Artemisinin Derivatives Basic Information List
Table Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales Market Share (%) in China (2012-2017)
Figure Botanical Extracts EPZ Ltd Artemisinin Derivatives Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Artemisinin Derivatives
Figure Manufacturing Process Analysis of Artemisinin Derivatives
Figure Artemisinin Derivatives Industrial Chain Analysis
Table Raw Materials Sources of Artemisinin Derivatives Major Players/Manufacturers in 2016
Table Major Buyers of Artemisinin Derivatives
Table Distributors/Traders List
Figure China Artemisinin Derivatives Sales (K MT) and Growth Rate (%) Forecast (2017-2022)
Figure China Artemisinin Derivatives Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Artemisinin Derivatives Price (USD/MT) Trend Forecast (2017-2022)
Table China Artemisinin Derivatives Sales (K MT) Forecast by Type (2017-2022)
Figure China Artemisinin Derivatives Sales (K MT) Forecast by Type (2017-2022)
Figure China Artemisinin Derivatives Sales Volume Market Share Forecast by Type in 2022
Table China Artemisinin Derivatives Sales (K MT) Forecast by Application (2017-2022)
Figure China Artemisinin Derivatives Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Artemisinin Derivatives Sales Volume Market Share Forecast by Application in 2022
Table China Artemisinin Derivatives Sales (K MT) Forecast by Regions (2017-2022)
Table China Artemisinin Derivatives Sales Volume Share Forecast by Regions (2017-2022)
Figure China Artemisinin Derivatives Sales Volume Share Forecast by Regions (2017-2022)
Figure China Artemisinin Derivatives Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources